theophylline has been researched along with Cardiovascular Diseases in 70 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Excerpt | Relevance | Reference |
---|---|---|
"Asthmatic patients receiving montelukast and, to some extent, low-dose theophylline have lower levels of CVD-associated inflammatory biomarkers and lipid levels." | 9.12 | The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. ( Allayee, H; Conti, DV; Hartiala, J; Irvin, CG; Lee, W; Lima, JJ; Mehrabian, M, 2007) |
"Theophylline is a useful drug for the treatment of asthma." | 7.73 | A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. ( Adachi, M; Fukuda, T; Kihara, N; Makino, S; Miyamoto, T; Nakajima, S; Nishima, S; Ohta, K, 2006) |
"Asthmatic patients receiving montelukast and, to some extent, low-dose theophylline have lower levels of CVD-associated inflammatory biomarkers and lipid levels." | 5.12 | The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. ( Allayee, H; Conti, DV; Hartiala, J; Irvin, CG; Lee, W; Lima, JJ; Mehrabian, M, 2007) |
"Theophylline is a useful drug for the treatment of asthma." | 3.73 | A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. ( Adachi, M; Fukuda, T; Kihara, N; Makino, S; Miyamoto, T; Nakajima, S; Nishima, S; Ohta, K, 2006) |
"Theophylline has long been a cornerstone of bronchodilator therapy for asthma and chronic obstructive lung disease, but until recently its use carried the risk of serious, even fatal, toxicity." | 3.67 | Theophylline therapy. Titrating dosage requirements. ( Uden, DL; Wyatt, RA; Zaske, DE, 1984) |
"Some recent epidemiologic studies have reported a nonlinear dose-response in the relationship between coffee consumption and health risks, such that the risks increase disproportionately to the increase in dose." | 2.67 | Dose-dependency of caffeine metabolism with repeated dosing. ( Benowitz, NL; Brown, CR; Denaro, CP; Jacob, P; Wilson, M, 1990) |
"Aminophylline therapy has undergone change in the past decade." | 2.37 | Aminophylline toxicity. ( Albert, S, 1987) |
"Theophylline was the main drug prescribed to in-patients discharged from hospital, although inhaling beta 2-agonists were also recommended in few cases." | 1.30 | [Respiratory medicine in the aged. Therapeutic problemsd]. ( Cossi, S; De Martinis, M; Ghisla, MK; Grassi, V; Leonardi, R; Tomasi, MF, 1997) |
"Although arrhythmias associated with myocardial infarction are managed primarily with drug therapy, those associated with acute respiratory failure respond best to adequate oxygenation and correction of metabolic and hemodynamic abnormalities." | 1.27 | Managing asthma and COPD in patients with cardiovascular disease. ( George, RB; Payne, DK, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 56 (80.00) | 18.7374 |
1990's | 4 (5.71) | 18.2507 |
2000's | 9 (12.86) | 29.6817 |
2010's | 1 (1.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, TA | 1 |
Pickard, AS | 1 |
Au, DH | 1 |
Bartle, B | 1 |
Weiss, KB | 1 |
Chen, Y | 1 |
Tu, JH | 1 |
He, YJ | 1 |
Zhang, W | 1 |
Wang, G | 1 |
Tan, ZR | 1 |
Zhou, G | 1 |
Fan, L | 1 |
Zhou, HH | 1 |
Schudt, C | 1 |
Hatzelmann, A | 1 |
Beume, R | 1 |
Tenor, H | 1 |
BERGER, F | 1 |
CELLI, L | 1 |
MUZIO, L | 1 |
BALZARINI, E | 1 |
HILLER, E | 1 |
THIESS, A | 1 |
OSBORN, DP | 1 |
SACHSSE, B | 1 |
BAMMELUND, E | 1 |
KAISER, R | 1 |
LINKE, H | 1 |
LANG, W | 1 |
PABST, HW | 1 |
SCHWALB, H | 1 |
HENSEL, H | 1 |
MULLER, R | 1 |
SCHILD, W | 1 |
ASCIONE, A | 2 |
VITALE, P | 2 |
LAMPRECHT, G | 1 |
BALDINI, L | 1 |
BRAMBILLA, G | 1 |
CAVALLINI, L | 1 |
BANSE, HJ | 1 |
ZAHNOW, W | 1 |
THURAU, H | 1 |
LANDEN, HC | 1 |
ARQUINT, A | 1 |
BLOECHLINGER, K | 1 |
BOGENMANN, E | 1 |
BARTOUSEK, V | 1 |
BRUCKNER, L | 1 |
CERNY, J | 1 |
DOLECEK, R | 1 |
EISLER, L | 1 |
FALK, G | 1 |
LERCHE, W | 1 |
HUNGER, H | 1 |
BROGLIA, F | 1 |
SPERLING, M | 1 |
MAU, G | 1 |
SCHENNETTEN, FP | 1 |
KUSZTOS, D | 1 |
HAFFNER, Z | 1 |
FEUSER, J | 1 |
LOOS, M | 1 |
WERKO, L | 1 |
LAGERLOF, H | 1 |
TARTARA, A | 1 |
McMICHAEL, J | 1 |
Makino, S | 1 |
Adachi, M | 1 |
Ohta, K | 1 |
Kihara, N | 1 |
Nakajima, S | 1 |
Nishima, S | 1 |
Fukuda, T | 1 |
Miyamoto, T | 1 |
Allayee, H | 1 |
Hartiala, J | 1 |
Lee, W | 1 |
Mehrabian, M | 1 |
Irvin, CG | 1 |
Conti, DV | 1 |
Lima, JJ | 1 |
Nishii, M | 1 |
Izumi, T | 1 |
Sanner, B | 1 |
Schäfer, T | 1 |
Uden, DL | 1 |
Wyatt, RA | 1 |
Zaske, DE | 1 |
Minton, NA | 1 |
Henry, JA | 1 |
Leonardi, R | 1 |
Cossi, S | 1 |
De Martinis, M | 1 |
Ghisla, MK | 1 |
Tomasi, MF | 1 |
Grassi, V | 1 |
Quinn, MJ | 1 |
Fitzgerald, DJ | 1 |
Hirooka, K | 1 |
Shimizu, M | 1 |
Mineshita, S | 1 |
Dini, FL | 1 |
Cogo, R | 1 |
Magazanik, NA | 1 |
Rhomberg, F | 1 |
Denaro, CP | 1 |
Brown, CR | 1 |
Wilson, M | 1 |
Jacob, P | 1 |
Benowitz, NL | 1 |
Sato, S | 1 |
Levy, G | 1 |
Stanley, R | 1 |
Comer, T | 1 |
Taylor, JL | 1 |
Saliba, D | 1 |
Sollevi, A | 1 |
Albert, S | 1 |
George, RB | 1 |
Payne, DK | 1 |
Schulz, FH | 1 |
Hapke, HJ | 2 |
Ruggerini, R | 1 |
Grugni, P | 1 |
Bolognesi, L | 1 |
Romitti, M | 1 |
Poggi, G | 1 |
Senini, G | 1 |
Inga, EF | 1 |
Duchêne-Marullaz, P | 1 |
Lavarenne, J | 1 |
Hartmann, K | 1 |
Van Schepdael, J | 1 |
Solvay, H | 1 |
Molino, N | 1 |
Belluardo, C | 1 |
Molino, S | 1 |
Bross, W | 1 |
Bross, T | 1 |
Kozuszek, W | 1 |
Olejak, B | 1 |
Kustrzycki, A | 1 |
Koltowski, R | 1 |
Meschino, S | 1 |
Meoni, S | 1 |
Massari, F | 1 |
Fontana, F | 1 |
Pelster, C | 1 |
Overbeck, P | 1 |
Bergsdorf, M | 1 |
Erfurth, HJ | 1 |
Görlich, N | 1 |
Neuffer, F | 1 |
Schotten, EW | 1 |
Spohd, H | 1 |
Zettel, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparative Effectiveness of COPD Assessment and Management Bundle Versus Usual Care in Patients Suspected of Having COPD[NCT01833026] | 56 participants (Actual) | Interventional | 2013-03-31 | Completed | |||
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)[NCT03137303] | Phase 3 | 402 participants (Actual) | Interventional | 2017-07-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
accuracy of diagnosis was the outcome measure. The results of the spirometry test (done in the beginning for the intervention group and ant the end of 1 year for the usual care groups) were reviewed in conjunction with the initial physician diagnosis of COPD and/or asthma to confirm whether the diagnosis was accurate, not accurate, or indeterminate. Accuracy of diagnosis of COPD was determined by spirometry results if the FEV1/FVC ratio was <0.7. (NCT01833026)
Timeframe: spirometry was performed at the first visit for intervention group and at 1 year from recruitment for the usual care group, one time assessment for both groups
Intervention | Participants (Count of Participants) |
---|---|
COPD Assessment and Management Recommendations | 10 |
Usual Care | 5 |
Determine differences in healthcare visits which include all-cause and respiratory related, acute care outpatient visits, emergency department visits, and hospitalizations between groups (NCT03137303)
Timeframe: 1 year
Intervention | Participants (Count of Participants) | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emergency room visit72551318 | Emergency room visit72551317 | Hospitalization72551317 | Hospitalization72551318 | Acute outpatient visit72551318 | Acute outpatient visit72551317 | Routine primary care visits72551317 | Routine primary care visits72551318 | New diagnostic tests72551318 | New diagnostic tests72551317 | |||||||||||||||||||||
No | Missing | Yes | ||||||||||||||||||||||||||||
Patient Subject Usual Care | 111 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 76 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 119 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 93 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 1 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 48 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 17 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 182 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 152 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 61 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 35 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 169 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 134 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 198 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 138 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 32 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 31 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 2 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 126 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 72 | |||||||||||||||||||||||||||||
Patient Subject Usual Care | 104 | |||||||||||||||||||||||||||||
Patient-Subject Intervention | 97 |
9 reviews available for theophylline and Cardiovascular Diseases
Article | Year |
---|---|
Phosphodiesterase inhibitors: history of pharmacology.
Topics: Animals; Asthma; Bronchodilator Agents; Cardiovascular Diseases; Humans; Nitric Oxide; Phosphodieste | 2011 |
[Cardiotoxicity of non-cardiac drugs].
Topics: Anthracyclines; Antineoplastic Agents; Cardiovascular Diseases; Ergotamine; Histamine H2 Antagonists | 2007 |
[Central sleep apnea syndrome].
Topics: Acetazolamide; Altitude Sickness; Anticonvulsants; Bronchodilator Agents; Cardiovascular Diseases; C | 2008 |
Acute and chronic human toxicity of theophylline.
Topics: Bronchodilator Agents; Cardiovascular Diseases; Central Nervous System Diseases; Drug Monitoring; Ga | 1996 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bo | 1999 |
Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
Topics: Animals; Arrhythmias, Cardiac; Asthma; Bronchodilator Agents; Cardiovascular Diseases; Drug Evaluati | 2001 |
Cardiovascular effects of adenosine in man; possible clinical implications.
Topics: Adenosine; Cardiovascular Diseases; Cardiovascular System; Humans; Hypoxia; Ischemia; Purines; Recep | 1986 |
Aminophylline toxicity.
Topics: Adolescent; Aminophylline; Cardiovascular Diseases; Child; Gastrointestinal Diseases; Humans; Kineti | 1987 |
[Recent data on coronary dilators].
Topics: Amino Alcohols; Aminophylline; Animals; Benzofurans; Cardiovascular Diseases; Cats; Coronary Disease | 1968 |
2 trials available for theophylline and Cardiovascular Diseases
Article | Year |
---|---|
The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics.
Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Biomarkers; C-Reactive Protein; Cardiovascular Disea | 2007 |
Dose-dependency of caffeine metabolism with repeated dosing.
Topics: Adult; Caffeine; Cardiovascular Diseases; Coffee; Dose-Response Relationship, Drug; Female; Humans; | 1990 |
59 other studies available for theophylline and Cardiovascular Diseases
Article | Year |
---|---|
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov | 2008 |
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov | 2008 |
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov | 2008 |
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov | 2008 |
Praxinor: abuse and dependence.
Topics: Cardiovascular Diseases; Drug Combinations; Humans; Hypotension, Orthostatic; Substance-Related Diso | 2009 |
Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
Topics: Adolescent; Adult; Caffeine; Cardiovascular Diseases; Cytochrome P-450 CYP1A2; Enzyme Activation; Hu | 2009 |
[Results with bilophyllin].
Topics: Bile Acids and Salts; Cardiovascular Diseases; Salts; Theophylline | 1952 |
[Effect of 1,3-dimethylxanthine ethylendiamine on gastric secretion of hydrochloric acid in heart diseases].
Topics: Aminophylline; Cardiovascular Diseases; Gastric Juice; Heart Diseases; Hydrochloric Acid; Metabolic | 1952 |
[Clinical and oscillographic studies on the activity of a new watersoluble theophylline derivative, DHT].
Topics: Cardiovascular Diseases; Theophylline | 1953 |
[Effect of theophylline preparation on blood circulation].
Topics: Cardiovascular Diseases; Humans; Theophylline | 1953 |
The use of buthoids (butaphyllamine suppositories) as adjuncts in the treatment of cardiovascular disease.
Topics: Cardiovascular Diseases; Pessaries; Suppositories; Theophylline | 1953 |
[Therapy of cardiovascular disorders and hypertension with a new purine derivative].
Topics: Cardiovascular Diseases; Humans; Hypertension; Purines; Theophylline | 1953 |
[Experiences in the clinical application of oxyethyltheophylline (cordalin)].
Topics: Cardiovascular Diseases; Humans; Theophylline | 1953 |
[Study and experience report of aerosol therapy with theophylline derivatives].
Topics: Aerosols; Bronchi; Bronchial Diseases; Cardiovascular Diseases; Disease; Heart Diseases; Theophyllin | 1954 |
[The mode of action and clinical significance of theophylline].
Topics: Cardiovascular Diseases; Kidney; Theophylline | 1954 |
[The diuretic effects oxyethyl-theophylline].
Topics: Cardiovascular Diseases; Diuretics; Theophylline | 1954 |
[On the treatment of acute cerebral and cardiac blood circulation disorders].
Topics: Brain; Cardiac Glycosides; Cardiovascular Diseases; Heart; Humans; Hypoxia; Theophylline | 1955 |
[Therapy of circulatory disorders in epidemic hepatitis].
Topics: Cardiovascular Diseases; Hepatitis; Hepatitis A; Hypotension; Theophylline | 1956 |
[Clinicotherapeutic research on a new synthetic theophylline derivative].
Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline | 1956 |
[Clinicotherapeutic research on a new synthetic theophylline derivative].
Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline | 1956 |
[Clinicotherapeutic research on a new synthetic theophylline derivative].
Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline | 1956 |
[Clinicotherapeutic research on a new synthetic theophylline derivative].
Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline | 1956 |
[Clinical experiences with the new vasodilator permanil].
Topics: Adenosine; Cardiovascular Diseases; Theophylline; Tissue Extracts; Vasodilator Agents | 1957 |
[Theophylline-sparteine-induced ventricular fibrillation in rat].
Topics: Animals; Cardiovascular Diseases; Rats; Sparteine; Theophylline; Ventricular Fibrillation | 1957 |
[Therapeutic activity of choline theophyllinate associated with papaverine trichlorohydroxyethyl-p-aminobenzoate].
Topics: Cardiovascular Diseases; Choline; Humans; Papaverine; para-Aminobenzoates; Theophylline | 1958 |
[New medicinal treatment possibilities of angiopathy in diabetics with 3-(methyloxyethylamino)-2-oxyprophyltheophylline nicotinate (complamin)].
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Niacin; Nicotinic Acids; Theophy | 1958 |
[New and authenticated theories from the area of theophylline and strophanthin therapy].
Topics: Cardiovascular Diseases; Humans; Strophanthins; Theophylline; Vasoconstrictor Agents; Vasodilator Ag | 1959 |
[Adenosine in cardiovascular disorders].
Topics: Adenosine; Cardiovascular Diseases; Theophylline | 1959 |
[The treatment of circulation disorders of various origins with Thenucline].
Topics: Brain; Cardiovascular Diseases; Cardiovascular System; Nucleosides; Nucleotides; Theophylline | 1960 |
[Therapy of brain circulatory disorders in chronic cor pulmonale].
Topics: Brain; Brain Diseases; Cardiovascular Diseases; Chronic Disease; Humans; Hypertension, Pulmonary; Pu | 1961 |
[Clinical contribution to the treatment of peripheral circulation disorders with Complamine].
Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul | 1961 |
[Clinical observations in the treatment of AV block with peripherin (Homburg)].
Topics: Atrioventricular Block; Cardiovascular Diseases; Diuretics; Ephedrine; Heart; Heart Block; Peripheri | 1961 |
[Clinical experiences with soluble theophylline derivatives].
Topics: Cardiovascular Diseases; Humans; Theophylline | 1959 |
[Clinical trial of the treatment of peripheral circulation disorders with Complamine].
Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul | 1962 |
[Contribution to the therapy of blood circulation disorders and degenerative changes of the fundus oculi].
Topics: Cardiovascular Diseases; Fundus Oculi; Humans; Niacin; Nicotinic Acids; Optic Nerve; Retina; Theophy | 1962 |
[HOW DOES THE HEPATOCARDIAL SYNDROME AFFECT THE CARDIOVASCULAR SYSTEM?WITH DIRECTIONS FOR DRUG AND DIET THERAPY].
Topics: Cardiovascular Diseases; Cardiovascular System; Diet; Diet Therapy; Diuretics; Heart Failure; Hepati | 1963 |
[USE OF PERIPHERIN-HOMBURG IN CIRCULATORY DISEASES OF THE BRAIN].
Topics: Brain; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Ephedrine; Humans; I | 1964 |
[A CONTRIBUTION TO COMPLAMIN TREATMENT].
Topics: Arteriosclerosis Obliterans; Biomedical Research; Cardiovascular Diseases; Coronary Disease; Drug Th | 1964 |
[ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)].
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Drug Therapy; Niacin; Nicotinic Acids; Theophyll | 1964 |
[THE ORAL USE OF PURE THEOPHYLLINE--CLINICAL EXPERIENCES WITH SOLOSIN].
Topics: Administration, Oral; Biomedical Research; Cardiovascular Diseases; Drug Therapy; Theophylline | 1964 |
Studies on the circulation of blood in man. VII. The effect of a single intravenous dose of theophylline diethanolamine on cardiac output, pulmonary blood volume and systemic and pulmonary blood pressures in hypertensive cardiovascular disease.
Topics: Blood Pressure; Blood Volume; Cardiac Output; Cardiovascular Diseases; Ethanolamines; Heart; Humans; | 1950 |
[Therapeutic effect of theophylline acetic acid with sparteine (sparteine mono- and di-theophylline acetate)].
Topics: Acetates; Acetic Acid; Cardiovascular Diseases; Humans; Sparteine; Theophylline | 1951 |
The principle of venous pressure reduction in the treatment of heart failure.
Topics: Blood Pressure; Cardiovascular Diseases; Digitalis; Digitalis Glycosides; Diuresis; Diuretics; Heart | 1950 |
A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Asthmatic Agents; Asthma; Bronchiti | 2006 |
Theophylline therapy. Titrating dosage requirements.
Topics: Administration, Oral; Adolescent; Age Factors; Asthma; Cardiovascular Diseases; Child; Child, Presch | 1984 |
[Respiratory medicine in the aged. Therapeutic problemsd].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Anti-Bacterial Agents; A | 1997 |
Theophylline metabolism after cardiac surgery.
Topics: Adult; Aminophylline; Cardiac Surgical Procedures; Cardiovascular Diseases; Cytochrome P-450 Enzyme | 2001 |
[Disorders of bronchial patency and their treatment in circulatory insufficiency].
Topics: Adrenal Cortex Hormones; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Blood Pressure; Bronch | 1977 |
[General medical concepts for the dental treatment of aging patients].
Topics: Aged; Aging; Asthma; Cardiovascular Diseases; Cortisone; Dietary Carbohydrates; Emergencies; Geriatr | 1977 |
Systemic effect of ipecac on acute toxicity of phenobarbital and theophylline in rats.
Topics: Animals; Cardiovascular Diseases; Ipecac; Male; Nervous System Diseases; Phenobarbital; Rats; Rats, | 1989 |
Mexiletine-theophylline interaction.
Topics: Aged; Amiodarone; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Interactions; Drug | 1989 |
Managing asthma and COPD in patients with cardiovascular disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Asthma; Cardiovascular Diseases; Digitalis; Digitalis Glycosides; | 1985 |
[Some problems of practical geriatrics].
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Analgesics; Cardiovascular Diseases; Chemical and Dr | 1974 |
[Management of heart and circulation. 1. Circulatory agents].
Topics: Adrenergic alpha-Antagonists; Animals; Caffeine; Cardiovascular Diseases; Peptides; Theophylline; Va | 1973 |
[The treatment of heart and circulatory disorders. 1. Circulatory drugs].
Topics: Acridines; Angiotensin II; Animals; Blood Pressure; Caffeine; Cardiovascular Diseases; Cardiovascula | 1973 |
[Clinical, anesthesiological and electroencephalographic findings in penthrane narcosis with and without hemokinetic treatment].
Topics: Adolescent; Adult; Anesthesia; Cardiovascular Diseases; Cerebrovascular Circulation; Electroencephal | 1973 |
[Results of the treatment of cardiovascular symptoms with Cardiopon].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Female; Humans; Long-Term Care; Male; Middle Aged; | 1969 |
[Clinical trial of diniprophylline-phenobarbital (Corverum) in oppressive cardio-respiratory disorders].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Drug Combinations; Dyspnea; Female; Humans; | 1972 |
[The action of Teo-Caradrin in cardiovascular diseases. Our clinical experience].
Topics: Aged; Cardiac Glycosides; Cardiovascular Diseases; Diuresis; Electrocardiography; Female; Heart; Hum | 1969 |
Bronchodilators.
Topics: Alcohols; Aminophylline; Asthma; Bronchodilator Agents; Cardiovascular Diseases; Child; Child, Presc | 1970 |
[Rheographic examination following cardiovascular surgery].
Topics: Adult; Blood Volume; Cardiovascular Diseases; Collateral Circulation; Extremities; Female; Heart Val | 1970 |
[Proscillaridine A in association with theophylline, ethylcrotylbarbituric acid and mecloxamine in clinical practice].
Topics: Adult; Aged; Arrhythmias, Cardiac; Arteriosclerosis; Barbiturates; Cardiovascular Diseases; Coronary | 1967 |
[Complamin Retard (Tika)].
Topics: Cardiovascular Diseases; Chemical Phenomena; Chemistry; Nicotinic Acids; Theophylline | 1968 |
[On the problem of stimulation of the blood circulation and blood coagulation. Studies on Akrinor].
Topics: Anticoagulants; Blood Coagulation; Cardiovascular Diseases; Coronary Disease; Ephedrine; Humans; Nor | 1969 |
[Taking into account myocardial metabolism in minor heart therapy].
Topics: Adult; Aged; Cardiovascular Diseases; Humans; Middle Aged; Myocardium; Plants, Medicinal; Theophylli | 1965 |